Skip to main content
. 2019 Apr 18;16:566–575. doi: 10.1016/j.omtn.2019.04.010

Table 1.

Comparison of Various Computational Approaches’ AUC Values through 5-Fold Cross-Validation

Method RWRMDA HDMP IMCMDA RLSMDA MIDP SPM NNMDA
Breast neoplasm 0.785 0.801 0.812 0.832 0.838 0.932 0.968
Hepatocellular carcinoma 0.749 0.759 0.744 0.794 0.807 0.918 0.966
Renal cell carcinoma 0.815 0.833 0.793 0.839 0.862 0.901 0.912
Squamous cell carcinoma 0.819 0.820 0.837 0.849 0.870 0.899 0.924
Colorectal neoplasm 0.793 0.802 0.766 0.831 0.845 0.885 0.927
Glioblastoma 0.680 0.700 0.781 0.714 0.786 0.840 0.911
Heart failure 0.722 0.770 0.924 0.738 0.821 0.950 0.945
Acute myeloid leukemia 0.839 0.858 0.861 0.853 0.915 0.957 0.916
Lung neoplasm 0.827 0.835 0.841 0.855 0.876 0.892 0.943
Melanoma 0.784 0.790 0.761 0.807 0.837 0.951 0.949
Ovarian neoplasm 0.882 0.884 0.875 0.909 0.923 0.949 0.928
Pancreatic neoplasm 0.871 0.895 0.894 0.887 0.945 0.954 0.954
Prostatic neoplasm 0.823 0.854 0.775 0.841 0.882 0.928 0.936
Stomach neoplasm 0.779 0.787 0.783 0.797 0.821 0.859 0.955
Urinary bladder neoplasm 0.821 0.850 0.813 0.845 0.897 0.898 0.920
Average AUC 0.799 0.816 0.817 0.826 0.862 0.914 0.937